I am a medical oncologist with interests in gynaecological and gastrointestinal cancers.
I am committed to providing research-focused best-evidence patient care whilst also conducting high quality clinical and translational research.
My research interests are in translational medicine in gynaecological and gastrointestinal cancers. I am lead investigator for a biomarker-driven clinical trial exploring the role of circulating tumour DNA as a marker of minimal residual disease in ovarian cancer. I am also involved in the colorectal and pancreatic cancer research programs at the institute.
I have a keen interest in cancer registries and registry trials and am on the Victorian Comprehensive Cancer Centre Steering Committee for Registry Trials.
A particular focus has been on exploring the impact of National Bowel Cancer Screening Program in colorectal cancer. I am also interested in personalising cancer medicine for all patients and am involved in the Precision Medicine Steering Committee as well.
I am actively involved in being the principal investigator on numerous clinical trials (Phase I-III) using novel biomarkers, and new cancer therapeutic agents including immunotherapy and other targeted agents to improve cancer treatment.
United Kingdom, King’s College London, MBBS
Australia, Royal Australasian College of Physicians, FRACP